{"filing":{"accession_number":"0001437749-26-019789","cik":"0000925741","ticker":"BCDA","company_name":"BioCardia, Inc.","form":"8-K","filing_date":"2026-06-08","report_date":null,"primary_document":"bcda20260607_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/925741/000143774926019789/bcda20260607_8k.htm"},"events":[{"id":6277,"run_id":5501,"accession_number":"0001437749-26-019789","anchor_item_number":"8.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"BioCardia sold 3,509,604 shares at $1.279 per share pursuant to an \"At The Market\" offering agreement with H.C. Wainwright \u0026 Co. This is a classic dilutive equity issuance under an ATM facility, which materially increases share count and dilutes existing shareholders. ATM offerings are a standard disclosure category under Item 3.02, though disclosed here under Item 8.01.","company_name":"BioCardia, Inc.","ticker":"BCDA","filing_date":"2026-06-08","form":"8-K","submitted_at":null,"items":[{"id":5062,"accession_number":"0001437749-26-019789","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"BioCardia sold 3,509,604 shares at $1.279 per share pursuant to an \"At The Market\" offering agreement with H.C. Wainwright \u0026 Co. This is a classic dilutive equity issuance under an ATM facility, which materially increases share count and dilutes existing shareholders. ATM offerings are a standard disclosure category under Item 3.02, though disclosed here under Item 8.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T12:01:08.062393+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":5062,"accession_number":"0001437749-26-019789","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"BioCardia sold 3,509,604 shares at $1.279 per share pursuant to an \"At The Market\" offering agreement with H.C. Wainwright \u0026 Co. This is a classic dilutive equity issuance under an ATM facility, which materially increases share count and dilutes existing shareholders. ATM offerings are a standard disclosure category under Item 3.02, though disclosed here under Item 8.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T12:01:08.062393+00:00","company_name":"BioCardia, Inc.","ticker":"BCDA","filing_date":"2026-06-08"}]}